Progressive nature of paroxysmal atrial fibrillation - Observations from a 14-year follow-up study

Circulation Journal

Volumn 68, Issue 6, 2004, Pages 568-572

  Kato, Takeshi ^a   Yamashita, Takeshi ^a   Sagara, Kouichi ^a   Iinuma, Hiroyuki ^a   Fu, Long Tai ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Aging; Antiarrhythmia agents; Fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; APRINDINE; ATENOLOL; BETAXOLOL; BISOPROLOL; CARTEOLOL; CARVEDILOL; CELIPROLOL; CIBENZOLINE; DISOPYRAMIDE; FLECAINIDE; METOPROLOL; MEXILETINE; PILSICAINIDE; PIRMENOL; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE;

ADULT; AMBULATORY MONITORING; ARTICLE; DEFIBRILLATION; DIRECT CURRENT; DISEASE COURSE; FEMALE; HEART ATRIUM FIBRILLATION; HEART DILATATION; HEART DISEASE; HEART INFARCTION; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; RECURRENT DISEASE; RISK FACTOR; VALVULAR HEART DISEASE;

AGE OF ONSET; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHRONIC DISEASE; DATA COLLECTION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RECURRENCE; RETROSPECTIVE STUDIES; TACHYCARDIA, PAROXYSMAL;

EID: 3042716088     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.568     Document Type: Article

References (27)

1. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, et al. The natural history of lone atrial fibrillation: A population-based study over three decades. N Engl J Med 1987; 317: 66-74.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
3. Takahashi N, Seki A, Imataka K, Fujii J. Clinical features of paroxysmal atrial fibrillation: An observation of 94 patients. Jpn Heart J 1981; 22: 14-49.
4. Waktare JE, Camm AJ. Acute treatment of atrial fibrillation: Why and when to maintain sinus rhythm. Am J Cardiol 1998; 81: 3C-15C.
5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-952.
6. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
7. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
9. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187-220.
10. Katoh T, Iinuma H, Inoue H, Ohe T, Ogawa S, Kasanuki H, et al. Multicenter prospective nonrandomized study of long-term antiarrhythmic drug therapy in patients with tachyarrhythmias: Japanese Antiarrhythmics Long-Term Study-2 (JALT-2 Study). Jpn Circ J 2001; 65: 275-278.
11. Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Bhandari AK, et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy: A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring (Flecainide Supraventricular Tachycardia Study Group). Circulation 1989; 80: 1557-1570.
12. Nichol G, McAlister F, Pham B, Laupacis A, Shea B, Green M, et al. Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 2002; 87: 535-543.
13. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968.
14. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997; 96: 3157-3163.
15. Goette A, Arndt M, Rocken C, Spiess A, Staack T, Geller JC, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000; 101: 2678-2681.
16. Yamashita T, Murakawa Y, Hayami N, Fukui E, Kasaoka Y, Inoue M, et al. Short-term effects of rapid pacing on mRNA level of voltage-dependent K(+) channels in rat atrium: Electrical remodeling in paroxysmal atrial tachycardia. Circulation 2000; 101: 2007-2014.
17. Kojima J, Niwano S, Moriguchi M, Ikeda K, Inuo K, Saito J, et al. Effect of pilsicainide on atrial electrophysiologic properties in the canine rapid atrial stimulation model. Circ J 2003; 67: 340-346.
18. Niwano S, Wakisaka Y, Kojima J, Yumoto Y, Inuo K, Hara H, et al. Monitoring the progression of the atrial electrical remodeling in patients with paroxysmal atrial fibrillation. Circ J 2003; 67: 133-138.
19. Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, et al. Asymptomatic or 'silent' atrial fibrillation: Frequency in untreated patients and patients receiving azimilide. Circulation 2003; 107: 1141-1145.
20. Wolk R, Kulakowski P, Karczmarewicz S, Karpinski G, Makowska E, Czepiel A, et al. The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone. Int J Cardiol 1996; 54: 207-211.
21. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
22. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98: 476-484.
23. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
24. Rossi A, Cicoira M, Zanolla L, Sandrini R, Golia G, Zardini P, et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1425.
25. Falk RH. Atrial fibrillation. N Engl J Med 2001; 344: 1067-1078.
26. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003; 41: 1690-1696.
27. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial. Lancet 2000; 356: 1789-1794.